The Race For A COVID-19 Vaccine, Know Your IPO: nCino, Lemonade CEO and MP Materials CEO

Mad Money w/ Jim Cramer

CNBC

News, Investing, Business

4.3 • 4K Ratings

🗓️ 23 July 2020

⏱️ 46 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

The Dow closed down 354 points and Jim Cramer is diving into the race for a vaccine for COVID-19. And, Cramer is breaking down nCino, a company that operates cloud based software for banks, after its IPO and what investors should look for when thinking about starting a position. Next, when life gives you lemons, get to know Lemonade - CEO Daniel Schreiber joins Cramer to discuss the newest IPO in the insurance sector and where the company is headed after its stellar debut. Plus, ahead of the merger with Fortress Value Acquisition Corp to bring the company public, MP Materials CEO James Litinsky checks in with Cramer.

Transcript

Click on a timestamp to play from that location

0:00.0	My mission is simple to make you money.
0:05.0	I'm here to level the playing field for all investors.
0:08.0	There's always a more work at Summer,
0:10.0	and I promised to help you find it.
0:12.0	Man money starts now.
0:16.0	Hey, I'm Kramer.
0:18.0	Welcome to Man of Money.
0:19.0	Welcome to Kramerica.
0:20.0	I'll be one of my friends.
0:21.0	I'm just trying to save you some money.
0:22.0	My job is not just to entertain, but educate,
0:24.0	and teach, and put this in context.
0:26.0	So call me at 1-800-7-3-CMBC,
0:29.0	or tweet me at Jim Kramer, a vaccine, a vaccine.
0:34.0	My kingdom for a vaccine.
0:37.0	Yeah, if you want to understand this market,
0:39.0	including today, the Dow tumbled 354 points.
0:42.0	S&P lost 1.2-3%, and then as I plunge,
0:46.0	the Hittiest 2.29%.
0:48.0	With many big cap tech stocks taking on the chin,
0:53.0	you have to recognize that things will never be the same
0:56.0	in this country or around the world until we get a vaccine.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.